Peter Hirth

9.4k citations
38 papers · 4.4k · 4 hit papers · h-index 19

Impact in

    • Pulmonary Hypertension Research and Treatments
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Neonatal Respiratory Health Research
    • Melanoma and MAPK Pathways
    • Fibroblast Growth Factor Research
    • Angiogenesis and VEGF in Cancer
    • Developmental Biology and Gene Regulation

Papers in

Peter Hirth

37 papers receiving 4.2k citations

Peter Hirth's Hit Papers

Vemurafenib: the first drug approved for BRAF-mutant cancer 2012 · 640 citations
6400+9+19Years since publication250500750

Peers

Peter Hirth
Comparison fields: 5 of 148
  • Pulmonary and Respiratory Medicine 1.2k
  • Molecular Biology 2.1k
  • Cancer Research 345
  • Oncology 566
  • Cell Biology 365
Replace Christine M. Sorenson with:
Christine M. Sorenson United States
Pradip K. Majumder United States
Stefania Mitola Italy
Antonino Passaniti United States
Martin Johansson Sweden
Daniel J. Lindner United States
Masahiko Miura Japan
Shih‐Wei Wang Taiwan
Howard S. Kruth United States
Mitsuharu Ueda Japan
Peter Hirth relative to Christine M. Sorenson United States Christine M. Sorenson's profile →
Citations per field
00.5×3.5×
Christine M. Sorenson · 1×
Citations per year

Countries citing papers authored by Peter Hirth

Since Specialization
Citations

This map shows the geographic impact of Peter Hirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hirth more than expected).

Fields of papers citing papers by Peter Hirth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hirth. The network helps show where Peter Hirth may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Hirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Hirth Line = papers co-authored together Peter Hirth links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors
Hit paper breakdown →
1997995
2
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Hit paper breakdown →
2000908
3
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
Hit paper breakdown →
2001661
4
Vemurafenib: the first drug approved for BRAF-mutant cancer
Hit paper breakdown →
2012640
5 1998443
6 198081
7 198876
8 201074
9 201759
10 198551
11 199651
12 198543
13 199842
14 201142
15 199935
16 200230
17 199530
18
Metal Supported Flow-Through Particulate Trap; a Non-Blocking Solution
200126
19 200120
20 199914

About Peter Hirth

Peter Hirth is a scholar working on Molecular Biology, Materials Chemistry, Oncology, Organic Chemistry and Automotive Engineering, having authored 38 papers that have together received 4.4k indexed citations. Recurring topics across this work include Catalytic Processes in Materials Science (8 papers), HER2/EGFR in Cancer Research (4 papers), Melanoma and MAPK Pathways (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Catalysts for Methane Reforming (3 papers), Computational Drug Discovery Methods (3 papers), Vehicle emissions and performance (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Molecular Biology (2.1k citations), Cancer Research (345 citations), Oncology (566 citations) and Cell Biology (365 citations). Peter Hirth has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Gerald McMahon, Norbert F. Voelkel, Rubin M. Tuder, Laimute Taraseviciene‐Stewart, Yasunori Kasahara, Johannes Waltenberger, Cho Tang, Li Sun, Stevan R. Hubbard and Brian Yeh. Their work appears in journals such as SAE technical papers on CD-ROM/SAE technical paper series, MTZ - Motortechnische Zeitschrift, FEBS Letters, Cold Spring Harbor Symposia on Quantitative Biology and Journal of Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact